CVE:VIV Avivagen (VIV) Stock Price, News & Analysis → Grab Your Free Bitcoin Today! (From Crypto Swap Profits) (Ad) Free VIV Stock Alerts C$0.0050 0.00 (0.00%) (As of 03/5/2024) Add Compare Share Share Today's RangeC$0.01▼C$0.0150-Day RangeC$0.01▼C$0.0152-Week RangeC$0.01▼C$0.08Volume2,820 shsAverage Volume49,827 shsMarket CapitalizationC$388,450.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesStock AnalysisChartEarningsHeadlines Get Avivagen alerts: Email Address Ad Behind the Markets4x Better than Bitcoin4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Avivagen Stock (CVE:VIV)Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.Read More VIV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VIV Stock News HeadlinesMarch 6, 2024 | investing.comAvivagen Inc (VIV)March 6, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - VIVMarch 29, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…February 20, 2024 | theglobeandmail.comAvivagen: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (VIV)January 3, 2024 | finance.yahoo.comPure Harvest Corporate Group, Inc. (PHCG)November 5, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Monday (VIV)October 17, 2023 | finance.yahoo.comAvivagen Announces New 500Kg Order for OxC-beta™August 25, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Friday (VIV)March 29, 2024 | Behind the Markets (Ad)Central Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.July 31, 2023 | technews.tmcnet.comAvivagen Provides Corporate UpdatesJuly 29, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc up on Friday (VIV)July 24, 2023 | finance.yahoo.comAvivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta™ Livestock ProductJuly 19, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Tuesday (VIV)July 15, 2023 | theglobeandmail.comAvivagen: Top 10 Undervalued Growth Stocks on TSX-V (VIV)June 27, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc down on Monday (VIV)May 25, 2023 | msn.comAn existing Avivagen customer increases order sizeMay 25, 2023 | finance.yahoo.comAvivagen Announces Significant Increase in Sales to an Existing CustomerMay 23, 2023 | sg.finance.yahoo.comAvivagen Inc. (VIV.V)May 18, 2023 | tmcnet.comAvivagen Announces Review of Strategic AlternativesApril 27, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc down on Thursday (VIV)April 19, 2023 | finance.yahoo.comAvivagen Announces AGM ResultsApril 7, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Thursday (VIV)April 6, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Wednesday (VIV)March 28, 2023 | finance.yahoo.comAvivagen Inc. Provides Update on Securities for Service Agreements With CEO and CSOMarch 18, 2023 | finance.yahoo.comAvivagen First Quarter 2023 Earnings: CA$0.015 loss per share (vs CA$0.027 loss in 1Q 2022)February 21, 2023 | msn.comAvivagen reports FY resultsFebruary 21, 2023 | finance.yahoo.comAvivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate GrowthSee More Headlines Receive VIV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avivagen and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/29/2024Next Earnings (Estimated)6/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:VIV CUSIPN/A CIKN/A Webwww.avivagen.com Phone613-949-8164FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-4,640,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-193.44% Debt Debt-to-Equity Ratio2,402.32 Current Ratio0.03 Quick Ratio0.30 Sales & Book Value Annual SalesC$403,780.00 Price / Sales0.96 Cash FlowC$0.00 per share Price / Cash Flow12.14 Book ValueC($0.10) per share Price / Book-0.05Miscellaneous Outstanding Shares77,690,000Free FloatN/AMarket CapC$388,450.00 OptionableNot Optionable Beta1.21 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. G. F. Kym Anthony (Age 68)CEO & Vice Chairman Comp: $361.06kDr. Graham Burton Ph.D.Co-Founder, Chief Scientific Officer & DirectorMr. Ira LevyInterim Chief Financial OfficerDr. James Nickerson Ph.D.President and Executive VP of Business Development & Product InnovationMr. Drew BasekDirector of Investor RelationsMs. Tracy Gillett BVSCDirector of Companion Animal & Marketing ManagerMore ExecutivesKey CompetitorsSugarBud Craft GrowersCVE:SUGRNeutriSci InternationalCVE:NUBioasis TechnologiesCVE:BTIImaging DynamicsCVE:IDLKiaroCVE:KOView All Competitors VIV Stock Analysis - Frequently Asked Questions How have VIV shares performed in 2024? Avivagen's stock was trading at C$0.01 at the beginning of 2024. Since then, VIV shares have increased by 0.0% and is now trading at C$0.01. View the best growth stocks for 2024 here. When is Avivagen's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024. View our VIV earnings forecast. What other stocks do shareholders of Avivagen own? Based on aggregate information from My MarketBeat watchlists, some companies that other Avivagen investors own include Astrotech (ASTC), Arcturus Therapeutics (ARCT), Aptose Biosciences (APTO), Appili Therapeutics (APLIF), Argan (AGX), Applied Genetic Technologies (AGTC), AES (AES) and AbbVie (ABBV). How do I buy shares of Avivagen? Shares of VIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:VIV) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaOnly a fool would buy Nvidia today… Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avivagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.